Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Latest William Jacobs Stories

2012-05-31 06:28:19

BRONX, N.Y., May 31, 2012 /PRNewswire-USNewswire/ -- The National Institutes of Health (NIH) has awarded researchers at Albert Einstein College of Medicine at Yeshiva University a five-year, $5.9 million grant to develop a new vaccine against tuberculosis (TB), including the toughest-to-treat forms of the disease known as multi drug-resistant and extensively drug-resistant. The grant will build on a new approach to TB vaccine design that is based on genetically altered Mycobacterium...

2012-02-16 12:30:00

With More than 15 Times the Solyndra Loan Guarantee on the Line, U.S. Taxpayers Being Kept in the Dark About Huge Vogtle Risks; Nine Groups Cite NRC Law Violation in Going to Court to Block Vogtle Licensing. WASHINGTON, Feb. 16, 2012 /PRNewswire-USNewswire/ -- If you are a taxpayer who liked the less than half a billion dollar Solyndra federal loan guarantee debacle, you will love the $8.33 billion loan guarantee to the even riskier Vogtle nuclear reactor project licensed last...

TB Vaccine Shows Promising Results In Lab Tests
2011-09-05 04:48:52

  Scientists at the Albert Einstein College of Medicine reported on Sunday that a vaccine they developed for tuberculosis had shown promising results during early laboratory testing in mice. Professor William Jacobs and colleagues, who published their findings in the journal Nature Medicine on Sunday, worked with Mycobacterium smegmatis, a species similar to tuberculosis that is lethal in mice but harmless to humans. "The researchers created a version of M. smegmatis lacking a...